This webinar highlights key challenges related to the recent U.S Food and Drug Administration (FDA) recall of several medicines containing Valsartan, following the detection of genotoxic impurities.
Rolf Kern from SCIEX will outline the current situation, explore the analytical methods used to characterize and quantify the impurities, and present a case study describing appropriate LC-MS methodology.
Attend this webinar to learn:
For insight into the current market situation with regards valsartan recall
To discover what the analytical method landscape looks like
To learn how an LC-QTOF based method can be used for both characterization and quantification of valsartan genotoxic impurities.
Rolf Kern Technical Marketing Manager
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK